Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Caredx Inc (NQ: CDNA )

7.860 -0.340 (-4.15%)
Streaming Delayed Price Updated: 3:35 PM EDT, Apr 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 404,707
Open 8.000
Bid (Size) 7.860 (2)
Ask (Size) 7.870 (6)
Prev. Close 8.200
Today's Range 7.740 - 8.320
52wk Range 4.800 - 12.93
Shares Outstanding 52,627,165
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CareDx to Report First Quarter 2024 Financial Results
From CareDx, Inc.
Via Business Wire
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From CareDx, Inc.
Via Business Wire

Performance

YTD
-34.17%
-34.17%
1 Month
-23.84%
-23.84%
3 Month
-20.45%
-20.45%
6 Month
+52.62%
+52.62%
1 Year
-5.30%
-5.30%

More News

Read More
CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
From CareDx, Inc.
Via Business Wire
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
From CareDx, Inc.
Via Business Wire
Recap: CareDx Q4 Earnings
Via Benzinga
Earnings Outlook For CareDx
Via Benzinga
CareDx Appoints Bryan Riggsbee to Its Board of Directors
From CareDx, Inc.
Via Business Wire
CareDx Announces Fourth Quarter and Full Year 2023 Financial Results
From CareDx, Inc.
Via Business Wire
CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference
From CareDx, Inc.
Via Business Wire
CareDx to Report Fourth Quarter and Full Year 2023 Financial Results
From CareDx, Inc.
Via Business Wire
CareDx: Q3 Earnings Insights
Via Benzinga
Earnings Outlook For CareDx
Via Benzinga
CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings
From CareDx, Inc.
Via Business Wire
3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List
Via InvestorPlace
CareDx Issues Statement in Patent Infringement Case
From CareDx, Inc.
Via Business Wire
Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle
Via Investor's Business Daily
Topics Intellectual Property
Exposures Intellectual Property
CareDx Adds to AlloSure Kidney and HeartCare Utility and Clinical Data at 2024 American Society of Transplant Surgeons Winter Symposium
From CareDx, Inc.
Via Business Wire
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2023
From CareDx, Inc.
Via Business Wire
CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication Adherence
From CareDx, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
CareDx Reports Third Quarter 2023 Results
From CareDx, Inc.
Via Business Wire
CareDx to Report Third Quarter 2023 Financial Results
From CareDx, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
CareDx Announces CEO Transition
From CareDx, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.